After the brutal murder of Azad, is there any hope for well-meaning routine calls for “dialogue” and “peace talks”? What can the "civil society" do as a serious, real intervention? It is reported that the decades-old talks with Naga insurgent groups has made some progress recently (See “DifferenCES ‘narrowed’,” Times of India, July 19, 2011). One reason why talks have a chance in these cases is that separatism comes in...

Calcuttans tried many a trick to fight the discomfiture induced by rolling power cuts today but a doctor in a pitch-dark labour room had little else other than a pack of cotton to help a lady who had become a mother minutes ago. The young mother lay in the labour room bleeding for 30 minutes this morning as the doctor could not stitch the cut in the feeble light of candles...

Over the last few decades thenon-party volunteer organisations have been much more effective in Indian public space and more articulate in policy debates than the traditional Left parties. This essay, while recognising the manifold achievements of these organisations, reflects on the serious limitations of the activities of the voluntary sector and argues that when they usurp certain roles they can become a threat to representative democracy. [Pranab Bardhan (bardhan@econ.berkeley.edu) is at...

A host of steel-manufacturing units are keen to set up plants in Karnataka, and all want captive mines. SOUTH KOREA'S Posco is not the only steel-maker keen to do business in Karnataka. The State's estimated 9,000 million tonnes of good-quality iron ore reserves, which is the second largest in India, the State government's assuranCES on a smooth land acquisition proCESs, the availability of water and the promise of speedy regulatory clearanCES...

India’s FTAs pip generic drugs production Lot More For Less     * Generic drugs from India play a major role as antiretroviral drugs across the developing world     * A 2010 study says 80% of the medicines used by donor-funded programmes to treat people with HIV were sourced from India     * It’s cut down treatment costs drastically, from $10,000 to $80     * Stronger IP regimes may hamper production of generics *** The right of...